Analgesic

An analgesic is any medication used to relieve pain. Analgesics form one of the most-prescribed medicine categories in the world, spanning everything from over-the-counter acetaminophen to powerful prescription opioids. The choice of analgesic depends on pain severity, type (nociceptive, neuropathic, inflammatory, visceral), patient factors, and the duration of expected use.

The World Health Organization analgesic ladder offers a stepwise framework. Step 1 uses non-opioid analgesics (acetaminophen, NSAIDs such as ibuprofen and naproxen) for mild pain. Step 2 adds weak opioids (tramadol, codeine) for moderate pain. Step 3 reserves strong opioids (morphine, hydromorphone, fentanyl) for severe pain. Adjuvant analgesics - gabapentin, pregabalin, duloxetine, amitriptyline - are added at any step for neuropathic pain. Although developed originally for cancer pain, the ladder remains a useful starting point.

Mechanistically, analgesics work in diverse ways. Acetaminophen acts centrally with poorly defined mechanisms (likely COX inhibition in the CNS plus cannabinoid pathway effects). NSAIDs inhibit cyclooxygenase enzymes (COX-1 and COX-2), reducing prostaglandin synthesis at sites of inflammation. Opioids bind mu, kappa, and delta opioid receptors in the brain and spinal cord, dampening pain signaling. Gabapentinoids modulate calcium channels in neurons that fire abnormally in neuropathic pain.

Clinically, the choice of analgesic must balance efficacy against risk. NSAIDs carry risks of gastrointestinal bleeding, kidney injury, and cardiovascular events - particularly in elderly patients or those with chronic kidney disease. Acetaminophen, while generally safe at therapeutic doses, is the leading cause of acute liver failure when taken in excess (more than 4 g/day in adults, less with chronic alcohol use). Opioids carry risks of respiratory depression, dependence, and overdose; the U.S. opioid crisis has reshaped prescribing toward shorter courses and lower doses.

A common misconception is that all pain responds equally to all analgesics. Neuropathic pain often responds poorly to opioids and NSAIDs but well to gabapentinoids and SNRIs. Another misconception is that acetaminophen is 'just like ibuprofen.' They have entirely different mechanisms, side effects, and contraindications - acetaminophen is preferred when bleeding or kidney disease is a concern, ibuprofen when inflammation is dominant.

Multimodal analgesia - combining medicines with different mechanisms at lower individual doses - is now standard for postoperative and chronic pain, optimizing relief while minimizing side effects.

Patient counseling on analgesics is essential to safety. For acetaminophen, the daily maximum (4 g in healthy adults, less in those with chronic alcohol use or liver disease) is easy to exceed when combination products are used - cold remedies, prescription opioid-acetaminophen combinations, and OTC sleep aids all contain acetaminophen. For NSAIDs, patients should be warned about taking them with other NSAIDs, the importance of food and adequate hydration, and the signs of GI bleeding (black stools, coffee-ground emesis). For opioids, naloxone co-prescription is now standard, along with secure storage, counseling on the dangers of combining with alcohol or benzodiazepines, and clear plans for tapering and disposal of unused medication.